TH135279B - Antibody constituents - VEGFR-3 antibodies - Google Patents

Antibody constituents - VEGFR-3 antibodies

Info

Publication number
TH135279B
TH135279B TH1301001119A TH1301001119A TH135279B TH 135279 B TH135279 B TH 135279B TH 1301001119 A TH1301001119 A TH 1301001119A TH 1301001119 A TH1301001119 A TH 1301001119A TH 135279 B TH135279 B TH 135279B
Authority
TH
Thailand
Prior art keywords
antibodies
vegfr
seq
antibody
constituents
Prior art date
Application number
TH1301001119A
Other languages
Thai (th)
Other versions
TH135279A (en
Inventor
บรอนนิสลอร์ เพอร์ซ็อด คริสนาแด็ทท์ ซาเย็ค นาธาลี ปิทาวสกี้
Original Assignee
อิมโคลนแอลแอลซี
Filing date
Publication date
Application filed by อิมโคลนแอลแอลซี filed Critical อิมโคลนแอลแอลซี
Publication of TH135279B publication Critical patent/TH135279B/en
Publication of TH135279A publication Critical patent/TH135279A/en

Links

Abstract

การประดิษฐ์นี้ได้ให้แอนติ-VEGFR-3 โมโนโคลนอลแอนติบอดี,องค์ประกอบทาง เภสัชกรรมซึ่งมีแอนติบอดีดังกล่าว และการใช้ของแอนติบอดีดังกล่าวในการรักษาโรค This invention yielded the anti-VEGFR-3 Monoclonal Antibody, Physical Composition Pharmaceuticals which contain such antibodies And the use of such antibodies in the treatment of disease.

Claims (1)

1.แอนติบอดีหรือส่วนจับเกาะแอนติเจนของมันที่จับเกาะอย่างจำเพาะกับ VEGFR-3มนุษย์ ซึ่งบรวมด้วย LCDR1 ของ SEQ ID NO 2,LCDR2 ของ SEQ ID NO 2, LCDR3 ของ SEQ ID NO 3, HCDR1 ของ SEQ ID NO 6, HCDR2 ของ SEQ ID NO 7 และ HCDR3 ของ SEQ ID NO 81. an antibody or its antigen-binding part that binds specifically to Human VEGFR-3 included LCDR1 of SEQ ID NO 2, LCDR2 of SEQ ID NO 2, LCDR3 of SEQ ID NO 3, HCDR1 of SEQ ID NO 6, HCDR2 of SEQ ID NO 7, and HCDR3 of SEQ ID NO 8.
TH1301001119A 2011-09-01 Antibody constituents - VEGFR-3 antibodies TH135279A (en)

Publications (2)

Publication Number Publication Date
TH135279B true TH135279B (en) 2014-07-21
TH135279A TH135279A (en) 2014-07-21

Family

ID=

Similar Documents

Publication Publication Date Title
PE20200011A1 (en) ANTI-PEPTIDE BETA AMYLOID N3pGlu ANTIBODIES AND THEIR USES
HRP20171992T1 (en) Cgrp antibodies
JP2016520514A5 (en)
NZ740221A (en) St2l antagonists and methods of use
NZ729158A (en) Anti-ctla4 monoclonal antibody or antigen binding fragment thereof, medicinal composition and use
PE20181326A1 (en) ANTIBODIES THAT SPECIFICALLY BIND PD-1 AND ITS USES
AU2016204274A1 (en) Antibodies that bind to OX40 and their uses
ES2687282T3 (en) ANTI-CD134 (OX40) humanized antibodies and their uses
NZ600768A (en) Human antibodies to human angiopoietin-like protein 4
PE20181090A1 (en) IMMUNE MODULATION AND TREATMENT OF SOLID TUMORS WITH ANTIBODIES THAT SPECIFICALLY BIND CD38
NZ714516A (en) Human antibodies to clostridium difficile toxins
BR112012024713A2 (en) "humanized antibody, humanized monoclonal antibody or antibody fragment, their uses, isolated polynucleotide, and pharmaceutical composition"
NZ606095A (en) Anti-n3pglu amyloid beta peptide antibodies and uses thereof
NZ595235A (en) Compositions and methods for increasing muscle growth
PE20181054A1 (en) HUMANIZED ANTI-CD19 ANTIBODIES AND METHODS OF USE
UA113623C2 (en) TISSUE FACTOR FACTOR (TFPI) MONOCLONAL ANTIBODY AGAINST TISSUE FACTOR INHIBITOR
ES2776179T3 (en) Antibodies directed against surface determinants of S. aureus
MX2014001373A (en) Drug composition for cancer treatment and/or prevention.
MX341958B (en) Antibodies against human il33r and uses thereof.
NZ709390A (en) Folate receptor 1 antibodies and immunoconjugates and uses thereof
NZ611269A (en) Neutralizing anti-ccl20 antibodies
AR103713A1 (en) ANTIBODIES AGAINST TAU AND ITS USES
PE20090161A1 (en) MONOCLONAL ANTIBODIES ANTI CXCL13
HRP20161587T1 (en) Bmp-6 antibodies
PE20141706A1 (en) TROMBINA UNION ANTIBODIES AND USES OF THE SAME